1. Market Research
  2. > Healthcare Market Trends
Next-Generation Oncology Devices and Solutions Market - A Global and Regional Analysis: Focus on Clinical Application, End User, Type, and Region - Analysis and Forecast, 2022-2031

Next-Generation Oncology Devices and Solutions Market - A Global and Regional Analysis: Focus on Clinical Application, End User, Type, and Region - Analysis and Forecast, 2022-2031

  • June 2022
  • 177 pages
  • ID: 6291291
  • Format: PDF
  • BIS Research

Summary

Table of Contents

Global Next-Generation Oncology Devices and Solutions Market to Reach $5,971.3 Million by 2031

Global Next-Generation Oncology Devices and Solutions Market Industry Overview

The global next-generation oncology devices and solutions market report highlights that the market was valued at $3,268.2 million in 2021 and is expected to reach $5,971.3 million by the end of 2031. The market is expected to grow at a CAGR of 6.41% during the forecast period from 2022 to 2031. The market is driven by factors such as the increasing prevalence of oncology, increasing demand for software solutions in oncology, emerging technologies in oncology testing and treatment, and rising preference for minimally invasive techniques of diagnosis and treatment.

Market Lifecycle Stage

The next-generation oncology devices and solutions market is still in the development phase. Increased research and development activities are underway to develop more products.

The opportunity for growth of the next-generation oncology devices and solutions market lies in the increasing demand for home-based cancer testing and the growing demand for targeted therapy.

Impact of COVID-19

The pandemic led to the deferral of cancer diagnosis by patients owing to factors such as the risk of virus transmission and higher priority given to the management of COVID-19 cases.Before the COVID-19 pandemic, cancer screening and treatment were majorly undertaken in hospitals and clinical facilities.

The emphasis on home-based oncology care was still in its nascent stage.The pandemic led to a deferral of screening and treatment for various types of cancers.

Owing to factors such as travel restrictions and risk of transmission of the virus, there was an increased demand for home-based care during the pandemic.While teleconsultations witnessed a drastic increase throughout the healthcare industry, there was also increased demand for home-based tests for screening and monitoring cancerous disorders.

Software solutions for oncology also witnessed higher demand as a result of the pandemic.

As the recovery phase of the COVID-19 pandemic begins, cancer diagnosis and treatment procedures are expected to normalize. The shift in preference to home-based care is expected to continue even after the pandemic subsides.

Market Segmentation:
Segmentation 1: by Clinical Application
• Lung Cancer
• Prostate Cancer
• Breast Cancer
• Others

The global next-generation oncology devices and solutions market in the clinical application segment is expected to be dominated by the breast cancer and the others segment.

Segmentation 2: by Type
• Devices
By Technology
o High-Intensity Focused Ultrasound
o Advanced Forms of Radiation Therapy
o Others
By Application
o Diagnosis
o Treatment and Monitoring
• Software
By Application
o Diagnosis
o Treatment and Monitoring

Segmentation 3: by End User
• Hospitals
• Diagnostic Imaging Centers
• Others

The global next-generation oncology devices and solutions in the end user segment is dominated by the hospital segment.

Segmentation 4: by Region

• North America - U.S., Canada
• Europe - Germany, France, U.K., Italy, Spain, Rest-of-Europe
• Asia-Pacific - Japan, China, India, Australia, South Korea, Rest-of-Asia-Pacific
• Rest-of-the-World - Kingdom of Saudi Arabia (K.S.A.), Brazil, U.A.E., Mexico, and Rest-of-Rest-of-the-World

Recent Developments in the Global Next-Generation Oncology Devices and Solutions Market

• In May 2022, Varian Medical Systems and HP partnered with Adaptiiv for supporting cancer treatment.
• In April 2022, Brainlab’s patient monitoring and positioning system secured CE Mark.
• In April 2022, GE Healthcare and Elekta entered into partnership to expand the access of precision radiation therapy solutions.
• In March 2022, Paige AI Inc. launched its latest product, Paige Breast Lymph Node.
• In March 2022, Paige AI Inc. launched its pathology AI for detecting breast cancer metastases in lymph nodes.
• In February 2022, Paige and Mindpeak announced partnership to expand the access of industry – leading AI software for breast cancer.
• In January 2022, Oulu University Hospital partnered with Varian and Siemens Healthcare to build a comprehensive ecosystem addressing cancer treatment pathway.
• In December 2021, UofL Health entered into collaboration with Paige AI Inc. to deploy cancer detection software suite of Paige AI Inc.
• In November 2021, Hologic received CE mark for Genius cervical cancer software.

Demand – Drivers and Limitations

Following are the drivers for the next-generation oncology devices and solutions market:
• Increasing Prevalence of Oncology and a Growing Geriatric Population
• Increase in Demand for Software Solutions in Oncology
• Emerging Technologies in Oncology Testing and Treatment
• Rising Preference for Minimally Invasive Techniques of Diagnosis and Treatment

The market is expected to face some limitations too due to the following challenges:
• Side Effects and Risks Associated with Cancer Treatment
• Dearth of Well-Trained and Skilled Professionals in Oncology

How Can This Report Add Value to an Organization?

Type: The ‘type’ segment helps the reader understand the different types of next-generation oncology devices and solutions available in the market.Moreover, the study provides the reader a detailed understanding of the different devices and solutions by clinical application (lung cancer, prostate cancer, breast cancer, and others).

Furthermore, the study also covers different segments of type ((Device (Technology (High-Intensity Focused Ultrasound, Advanced Forms of Radiation Therapy, and Others), Application (Diagnosis and Treatment and Monitoring)), Software (Application (Diagnosis and Treatment and Monitoring))).

Growth/Marketing Strategy: The global next-generation oncology devices and solutions market has seen major development by key players operating in the market, such as business expansion, partnership, collaboration, and joint venture.The favored strategy for the companies has been regulatory and legal activities, partnerships, alliances, and business expansions to strengthen their position in the market.

For instance, In April 2022, Brainlab’s patient monitoring and positioning system secured CE mark. In May 2022, Varian Medical Systems (a subsidiary of Siemens AG) and HP entered into a partnership with Adaptiiv to support cancer treatment.

Countries Covered
• North America
• U.S.
• Canada
• Europe
• Germany
• Italy
• France
• U.K.
• Spain
• Rest-of-Europe
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest-of-Asia-Pacific
• Rest-of-the-World
• Kingdom of Saudi Arabia (K.S.A.)
• Brazil
• U.A.E.
• Mexico
• Rest-of-Rest-of-the-World

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Healthcare IT Market Research Report by Product, Component, Deployment, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • $ 3949
  • July 2022
  • 222 pages

Healthcare IT Market Research Report by Product (Clinical Decision Support System, Electronic Health Record, and Healthcare Analytics), Component, Deployment, End User, Region (Americas, Asia-Pacific, ...

  • World
  • Healthcare IT
  • Healthcare
  • Industry analysis

ref:plp2022

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on